<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00772044</url>
  </required_header>
  <id_info>
    <org_study_id>C009</org_study_id>
    <nct_id>NCT00772044</nct_id>
  </id_info>
  <brief_title>Randomized Study of Provent Versus Sham Device to Treat Obstructive Sleep Apnea</brief_title>
  <acronym>AERO</acronym>
  <official_title>Randomized, Double-blind Study to Compare Safety and Effectiveness of the ProventTM Professional Sleep Apnea Therapy Device to Sham for the Non-invasive Treatment of OSAH</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ventus Medical, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ventus Medical, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Primary Endpoints:&#xD;
&#xD;
      â€¢Comparison of difference in AHI at one-week in-lab polysomnography between &quot;device on&quot; and&#xD;
      &quot;device off&quot; nights, controlling for sleep position (supine vs. non-supine)&#xD;
&#xD;
      Secondary Endpoints: By polysomnography, reduction in:&#xD;
&#xD;
        -  AHI with device on vs. off at 3 months, controlling for sleep position&#xD;
&#xD;
        -  Oxygen desaturation index with device on vs. off&#xD;
&#xD;
        -  Arousal index with device on vs. off&#xD;
&#xD;
        -  Duration of snoring with device on vs. off&#xD;
&#xD;
        -  Epworth Sleepiness Scale&#xD;
&#xD;
      Patient acceptance, in terms of:&#xD;
&#xD;
        -  Refusal rate at screening&#xD;
&#xD;
        -  Discontinuation rate during follow-up&#xD;
&#xD;
        -  Daily compliance rate&#xD;
&#xD;
        -  Device-related adverse events&#xD;
&#xD;
        -  Serious adverse events&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Please see summary above&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>November 2008</start_date>
  <completion_date type="Actual">December 2009</completion_date>
  <primary_completion_date type="Actual">September 2009</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Comparison of difference in AHI at one-week in-lab polysomnography between &quot;device on&quot; and &quot;device off&quot; nights, controlling for sleep position (supine vs. non-supine)</measure>
    <time_frame>3 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Reduction in AHI, Oxygen desat index, Arousal index &amp; Duration of snoring w/ device on/off;ESS,Patient acceptance,Device-related AEs &amp; SAEs</measure>
    <time_frame>3 months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">250</enrollment>
  <condition>Obstructive Sleep Apnea Hypopnea</condition>
  <condition>OSA</condition>
  <condition>OSAH</condition>
  <arm_group>
    <arm_group_label>Provent</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Those receiving the active device</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sham</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Those receiving sham device</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Provent Professional Sleep Apnea Therapy Device</intervention_name>
    <description>Application of active device (Provent)</description>
    <arm_group_label>Provent</arm_group_label>
    <other_name>Provent</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Sham Device</intervention_name>
    <description>Sham device will be applied</description>
    <arm_group_label>Sham</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Age &gt; 18 years&#xD;
&#xD;
          2. Diagnosis of OSA&#xD;
&#xD;
          3. AHI &gt; 10 on diagnostic PSG performed within last 3 months&#xD;
&#xD;
          4. Investigator believes that subject can benefit from OSA tx&#xD;
&#xD;
          5. Subject understands and is willing and able to comply with study requirements&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Use of any device that interferes with nasal/oral breathing&#xD;
&#xD;
          2. Persistent blockage of one or both nostrils&#xD;
&#xD;
          3. Any chronic sores or lesions on the inside/outside of the nose&#xD;
&#xD;
          4. Chronic use of nasal decongestants other than nasal steroids&#xD;
&#xD;
          5. Oxygen saturation &lt; 75% for &gt; 10% of the diag. PSG&#xD;
&#xD;
          6. Oxygen saturation &lt; 75% for &gt; 25% of the first 4 hours of the diag. PSG&#xD;
&#xD;
          7. Prior or near-miss motor vehicle accident due to sleepiness (last 12 mo.)&#xD;
&#xD;
          8. Current use of hypnotics, anxiolytics, sedating antidepressants, anticonvulsants,&#xD;
             sedating antihistamines, stimulants, or other medications likely to affect&#xD;
             neurocognitive function and/or alertness&#xD;
&#xD;
          9. History of allergic reaction to acrylic-based adhesives&#xD;
&#xD;
         10. Current acute upper respiratory inflammation/infection or perforation of the tympanic&#xD;
             membrane&#xD;
&#xD;
         11. History of frequent and/or poorly treated severe nasal allergies or sinusitis&#xD;
&#xD;
         12. Narcolepsy, idiopathic hypersomnolence, chronic insomnia, RLS, REM sleep behavior&#xD;
             disorder or any other diagnosed or suspected sleep disorder&#xD;
&#xD;
         13. Current use of diurnal or nocturnal supplemental oxygen&#xD;
&#xD;
         14. History of CPAP use in the home for OSA tx&#xD;
&#xD;
         15. History of use of oral appliances for OSA tx&#xD;
&#xD;
         16. History of prior surgery for OSA&#xD;
&#xD;
         17. Currently working night or rotating shifts&#xD;
&#xD;
         18. Consumption of &gt; 10 caffeinated beverages per day&#xD;
&#xD;
         19. History of severe cardiovasc. disease, including NYHA Class III or IV heart failure,&#xD;
             CAD with angina or MI/stroke in past 6 months&#xD;
&#xD;
         20. History of cardiac rhythm disturbance&#xD;
&#xD;
         21. Uncontrolled hypertension (SBP &gt; 180 or DBP &gt; 105 mm Hg)&#xD;
&#xD;
         22. Uncontrolled hypotension(SBP &lt; 80 or DBP &lt; 55 mm Hg&#xD;
&#xD;
         23. History of severe respiratory disorders or unstable respiratory disease&#xD;
&#xD;
         24. Any other serious, uncontrolled medical condition&#xD;
&#xD;
         25. Females of child bearing age who are pregnant or intending to become pregnant&#xD;
&#xD;
         26. Consumes more than 3 drinks of alcohol/day&#xD;
&#xD;
         27. Chronic neurologic disorders&#xD;
&#xD;
         28. Cancer, unless in remission for more than 1 year&#xD;
&#xD;
         29. Current psychiatric illness&#xD;
&#xD;
         30. Smokers whose habit interferes with the overnight PSG&#xD;
&#xD;
         31. Any known illicit drug usage&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Richard B Berry, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Florida</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Connie A Rey</last_name>
    <role>Study Director</role>
    <affiliation>Ventus Medical</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Pulmonary Associates</name>
      <address>
        <city>Glendale</city>
        <state>Arizona</state>
        <zip>85306</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Pulmonary Associates</name>
      <address>
        <city>Phoenix</city>
        <state>Arizona</state>
        <zip>85006</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Stanford Center for Human Sleep Research</name>
      <address>
        <city>Redwood City</city>
        <state>California</state>
        <zip>94063</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Gaylord Sleep Medicine</name>
      <address>
        <city>Wallingford</city>
        <state>Connecticut</state>
        <zip>06492</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Of Florida College of Medicine</name>
      <address>
        <city>Gainesville</city>
        <state>Florida</state>
        <zip>32610</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sleep Disorders Center of Georgia</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30342</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Chicago Sleep Group of Suburban Lung Associates</name>
      <address>
        <city>Elk Grove Village</city>
        <state>Illinois</state>
        <zip>60007</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kentucky Research Group</name>
      <address>
        <city>Louisville</city>
        <state>Kentucky</state>
        <zip>40217</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sleep Health Center</name>
      <address>
        <city>Brighton</city>
        <state>Massachusetts</state>
        <zip>02135</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Wayne State University</name>
      <address>
        <city>Detroit</city>
        <state>Michigan</state>
        <zip>48201</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Borgess Research Institute</name>
      <address>
        <city>Kalamazoo</city>
        <state>Michigan</state>
        <zip>49048</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mayo Clinic</name>
      <address>
        <city>Rochester</city>
        <state>Minnesota</state>
        <zip>55905</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sleep Medicine and Research Center</name>
      <address>
        <city>Chesterfield</city>
        <state>Missouri</state>
        <zip>63017</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Corvallis Clinic</name>
      <address>
        <city>Corvallis</city>
        <state>Oregon</state>
        <zip>97330</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>SleepMed of South Carolina</name>
      <address>
        <city>Columbia</city>
        <state>South Carolina</state>
        <zip>29201</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sleep Medicine Associates of Texas</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75231</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sleep Therapy and Research Center</name>
      <address>
        <city>San Antonio</city>
        <state>Texas</state>
        <zip>07829</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2010</verification_date>
  <study_first_submitted>October 13, 2008</study_first_submitted>
  <study_first_submitted_qc>October 14, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 15, 2008</study_first_posted>
  <last_update_submitted>March 31, 2010</last_update_submitted>
  <last_update_submitted_qc>March 31, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 1, 2010</last_update_posted>
  <responsible_party>
    <name_title>Connie Rey, Director, Clinical Affairs</name_title>
    <organization>Ventus Medical, Inc.</organization>
  </responsible_party>
  <keyword>OSA</keyword>
  <keyword>sleep apnea</keyword>
  <keyword>apnea</keyword>
  <keyword>AHI</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Apnea</mesh_term>
    <mesh_term>Sleep Apnea Syndromes</mesh_term>
    <mesh_term>Sleep Apnea, Obstructive</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

